Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells - Meslier, Y; André, S; Dimitrov, J D (J Thromb Haemost, 2011)
, et al.